|
ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE
|
2R44CA114126-02
|
$419,983
|
$209,992
|
Lim, Mark
|
AMBERGEN, INC
|
|
NR4A Nuclear Receptor Function in Leukemia
|
5R01CA111411-03
|
$258,529
|
$258,529
|
CONNEELY, ORLA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$1,173
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$15,150
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel Strategies for Treatment of Myeloproliferative Disorders
|
1R01CA131664-01A1
|
$352,750
|
$352,750
|
KHOSRAVI-FAR, ROYA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Oncogene-Induced Evasion from Apoptosis
|
5R01CA105306-04
|
$318,352
|
$318,352
|
KHOSRAVI-FAR, ROYA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting Leukemic Stem Cells
|
1R01CA138211-01
|
$350,261
|
$175,131
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Nucleophosmin in Fanconi's Anemia-evolved Leukemia
|
5R01CA109641-05
|
$289,623
|
$144,812
|
PANG, QISHEN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Resistance of CML Stem Cells to Imatinib (Gleevec)
|
2R01CA095684-05
|
$321,555
|
$321,555
|
BHATIA, RAVI
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
2P30CA033572-25
|
$2,342,475
|
$46,850
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S1
|
$95,134
|
$1,903
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-25S2
|
$107,415
|
$2,148
|
FIGLIN, ROBERT
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-05
|
$2,163,322
|
$540,831
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$1,434
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$116,418
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
2P01CA066996-11A1
|
$2,299,041
|
$321,866
|
GILLILAND, D
|
DANA-FARBER CANCER INSTITUTE
|
|
Signaling and targeting of FGFR1 fusions in 8p11 myeloproliferative syndrome
|
5R01CA120272-03
|
$263,700
|
$263,700
|
Chen, Jing
|
EMORY UNIVERSITY
|
|
Adult Leukemia Research Center
|
3P01CA018029-33S1
|
$140,652
|
$35,163
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Adult Leukemia Research Center
|
5P01CA018029-33
|
$4,943,916
|
$1,235,979
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S4
|
$9,979,932
|
$199,599
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S5
|
$60,810
|
$1,216
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-34S6
|
$264,000
|
$5,280
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Examination of imatinib mesylate resistance in CML
|
5K23CA106796-05
|
$133,650
|
$133,650
|
Oehler, Vivian
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Mixed Hematopoietic Chimerism after Stem Cell Allografts
|
5P01CA078902-10
|
$2,003,834
|
$340,652
|
Storb, Rainer
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-10S1
|
$125,023
|
$3,751
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
3P30CA076292-10S2
|
$193,710
|
$5,811
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Moffitt Cancer Center Support Grant
|
5P30CA076292-10
|
$2,780,246
|
$83,407
|
DALTON, WILLIAM
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Modulation of T cell Homeostasis in Myelodysplastic Syndrome (MDS)
|
1R01CA129952-01A1
|
$288,000
|
$288,000
|
EPLING-BURNETTE, Pearlie K
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Phosphatase Targets of Lenalidomide in Myelodysplastic Syndrome
|
1R01CA131076-01
|
$466,719
|
$466,719
|
LIST, ALAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Src Kinases in Ph+ Lymphoblastic Leukemia
|
5R01CA114199-04
|
$284,832
|
$284,832
|
LI, SHAOGUANG
|
JACKSON LABORATORY
|
|
Cancer Center Support (CORE) Grant
|
3P30CA034196-25S1
|
$94,360
|
$14,154
|
WOYCHIK, RICHARD
|
JACKSON LABORATORY
|
|
Cancer Center Support (CORE) Grant
|
3P30CA034196-25S2
|
$66,120
|
$9,918
|
WOYCHIK, RICHARD
|
JACKSON LABORATORY
|
|
Cancer Center Support (CORE) Grant
|
5P30CA034196-25
|
$2,256,340
|
$338,451
|
WOYCHIK, RICHARD
|
JACKSON LABORATORY
|
|
International Symposium on Juvenile Myelomonocytic Leukemia
|
3R13CA132568-01S1
|
|
$0
|
Loh, Mignon
|
JMML FOUNDATION
|
|
International Symposium on Juvenile Myelomonocytic Leukemia
|
5R13CA132568-02
|
$7,500
|
$7,500
|
Loh, Mignon
|
JMML FOUNDATION
|
|
Telomere Shortening and Stem Cell Maintenance
|
5K08CA118416-03
|
$140,010
|
$140,010
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Program on Molecular and Cellular Mechanisms of Tumorigenesis
|
5P01CA016519-33
|
$1,872,378
|
$187,238
|
BOEKE, Jef
|
JOHNS HOPKINS UNIVERSITY
|
|
Arsenic Trioxide in Primary Curative APL Therapy
|
5R01CA100904-05
|
$420,352
|
$210,176
|
GORE, STEVEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Mechanism of combined 'epigenetic therapy' in myeloid malignancies
|
5R01CA125635-02
|
$476,730
|
$238,365
|
GORE, STEVEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-33
|
$2,910,583
|
$582,117
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-46
|
$7,420,697
|
$148,414
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
FUNCTIONAL PROTEOMICS OF LEUKEMIC MARROW STROMAL CELLS
|
5R33CA092731-05
|
$485,894
|
$325,549
|
SESHI, BEERELLI
|
LA BIOMED RES INST/ HARBOR UCLA MED CTR
|
|
Nostalgia in the WNT signaling pathway; fatty acids, epigenetics and leukemia
|
1R03CA129790-01A1
|
$70,000
|
$70,000
|
SOLLARS, VINCENT
|
MARSHALL UNIVERSITY
|
|
Genetic Analysis of Myeloproliferative Disease
|
7R01CA076167-07
|
$286,425
|
$286,425
|
COWELL, JOHN
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
MYELOPROLIFERATIVE DISORDERS RESEARCH CONSORTIUM
|
5P01CA108671-03
|
$4,612,519
|
$4,612,519
|
Hoffman, Ronald
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Therapy
|
Z01 SC 010288
|
$942,078
|
$47,104
|
Fowler, Daniel
|
CCR (NCI)
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $31,297,852
|